Home › Research › Tau biomarkers
Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India
Huded CB, Bharath S, Chandra SR, Sivakumar PT, Varghese M, Subramanian S.. Asian journal of psychiatry, 2014-11-06
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
The present study was undertaken to validate the measurement of biomarkers as a supplement to the latest diagnostic criteria for Alzheimer disease (AD) dementia by National Institute on Aging-Alzheimer's Association (NIA-AA) work group using a sample attending a tertiary care center in Southern India. A total of 20 subjects diagnosed clinically as Alzheimer's dementia according to the NIA-AA criteria for AD were included in the study. The CSF biomarkers Aβ42, t-tau, and p-tau181 were assessed.
What this study adds
Evidence grade: Low
The record lists 12 participants. In 20 patients in Southern India, this study measured cerebrospinal fluid amyloid, total tau and phosphorylated tau to support the NIA-AA diagnostic criteria for Alzheimer's dementia. It is about supporting diagnosis with biomarkers, not about treating, curing or preventing the disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Huded, C. B., Bharath, S., Chandra, SR., Sivakumar, P. T., Varghese, M., & Subramanian, S. (2015). Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India. Asian journal of psychiatry. https://doi.org/10.1016/j.ajp.2014.10.007
Vancouver
Huded CB, Bharath S, Chandra SR, Sivakumar PT, Varghese M, Subramanian S. Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India. Asian journal of psychiatry. 2015. doi:10.1016/j.ajp.2014.10.007. PMID: 25468261.
BibTeX
@article{huded2015-25468261,
author = {Huded, C. B. and Bharath, S. and Chandra, SR. and Sivakumar, P. T. and Varghese, M. and Subramanian, S.},
title = {{Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India}},
journal = {Asian journal of psychiatry},
year = {2015},
doi = {10.1016/j.ajp.2014.10.007},
pmid = {25468261},
url = {https://doi.org/10.1016/j.ajp.2014.10.007}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- A total of 20 subjects diagnosed clinically as Alzheimer's dementia according to the NIA-AA criteria for AD were included in the study.
- The CSF biomarkers Aβ42, t-tau, and p-tau181 were assessed.
- The biomarker results were compared among mild and moderate to severe AD as defined in the NIA-AA work group guidelines.
- The results revealed that the amount of Aβ42 was very low in all the 20 samples ( 1 (n=12). t-tau and p-tau levels were in the range of 39.45±5.09pg/ml and 13.06±7.32pg/ml for CDR 1 group. t-tau and p-tau levels were in the range of 49.9±11.28pg/ml and 33.94±15.13pg/ml for moderate to severe cases.
Why it matters
In 20 patients in Southern India, this study measured cerebrospinal fluid amyloid, total tau and phosphorylated tau to support the NIA-AA diagnostic criteria for Alzheimer's dementia. It is about supporting diagnosis with biomarkers, not about treating, curing or preventing the disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants12
- Evidence strengthLow
How this study scored 30/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Asian journal of psychiatry) |
| Journal's citation record | 1 / 4 | Asian Journal of Psychiatry: journal h-index 98 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2015 — within 20 year(s) of the newest study here |
| Sample size | 1 / 4 | 12 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 6 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 13 year(s) since 2015 |
| Impact for its field and year | 1 / 6 | Cited 0.7× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Sarada Subramanian: h-index 13 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | National Institute of Mental Health and Neurosciences: institution h-index 225 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 25468261) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 30 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 18.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.